RYBELSUS Trademark

Trademark Overview

On Monday, July 9, 2018, a trademark application was filed for RYBELSUS with the United States Patent and Trademark Office. The USPTO has given the RYBELSUS trademark a serial number of 79242284. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, April 1, 2025. This trademark is owned by Novo Nordisk A/S. The RYBELSUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes
rybelsus

General Information

Serial Number79242284
Word MarkRYBELSUS
Filing DateMonday, July 9, 2018
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, April 1, 2025
Registration Number5682853
Registration DateTuesday, February 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk A/S
Party Type30 - Original Registrant
Legal Entity Type65 - NOT AVAILABLE
AddressBagsvaerd DK-2880
DK
Party NameNovo Nordisk A/S
Party Type20 - Owner at Publication
Legal Entity Type65 - NOT AVAILABLE
AddressDK
Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events

Event DateEvent Description
Thursday, October 25, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 4, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 16, 2018APPLICATION FILING RECEIPT MAILED
Thursday, October 25, 2018TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, November 21, 2018NOTICE OF PUBLICATION
Friday, October 26, 2018ASSIGNED TO EXAMINER
Friday, October 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 11, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, March 28, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 2, 2019FINAL DISPOSITION PROCESSED
Monday, October 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 19, 2019NOTIFICATION PROCESSED BY IB
Monday, October 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 11, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 7, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, October 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 21, 2024TEAS SECTION 71 RECEIVED
Tuesday, April 1, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, April 1, 2025REGISTERED-SEC.71 ACCEPTED
Monday, April 7, 2025TEAS SECTION 15 RECEIVED
Tuesday, May 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 15, 2025REGISTERED - SEC. 15 ACKNOWLEDGED
Thursday, May 15, 2025SEC. 15 ACKNOWLEDGEMENT - E-MAILED

Related Keywords

rybelsus diabetes treatment preparations pharmaceutical